Thank you for visiting us at The Liver Meeting®

Posted: November 11, 2022

It’s Not Just Support. It’s Solutions.



Non-Invasive Tests for NASH and ALD Drug Development

We enjoyed meeting so many of you in-person at the AASLD The Liver Meeting®, and sharing new studies using CK18/K18-M30® and CK18/K18-M65® as blood-based biomarkers in the world of NASH, acute alcohol-associated hepatitis, and DILI.

DiaPharma has also added new and unique assay kits to assess liver injury and fibrosis. If you missed us, reach out to us today to discuss with one of our scientists.

For research use only in U.S. and Canada. Not for use in diagnostic procedures.

 Connect with Us


NASH ALD/AH metabolic disease DILI biomarkers hepatocyte apoptosis necrosis

It’s Not Just Support. It’s Solutions.

Celebrating 25 years of scientific expertise, just a call or click away.

diapharma bioassays hemostasis thrombosis chromogenic


DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846